FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015683003> ?p ?o ?g. }

• W2015683003 endingPage "1778" @default.
• W2015683003 startingPage "1773" @default.
• W2015683003 abstract "Purpose To report 4 pediatric Down syndrome patients with optic nerve elevation and pseudotumor cerebri. Design Retrospective observational case series. Participants Four pediatric Down syndrome patients found to have optic nerve elevation on ophthalmologic examination at a single institution. Methods Medical record review of 117 pediatric Down syndrome patients aged 0 to 18 years was performed. All patients were seen at the University of Wisconsin pediatric ophthalmology clinic between 1995 and 2005. Main Outcome Measures Visual acuity, optic nerve appearance, and neurologic work-up. Results Four (3.4%) of 117 Down syndrome patients seen at the university’s pediatric ophthalmology clinic were found to have optic nerve elevation. This included 2 boys and 2 girls, aged 2 to 10 years. None of the patients had a history of headache or transient visual obscuration. One of the patients had high hyperopia at the time of presentation, and all were referred for neurologic evaluation of suspected increased intracranial pressure. Three patients were diagnosed with pseudotumor cerebri (PTC) based on a normal brain magnetic resonance imaging (MRI) scan, an elevated opening cerebrospinal fluid (CSF) pressure on lumbar puncture, and normal CSF analysis results. The fourth patient’s elevated optic nerve appearance was likely secondary to PTC after obtaining normal brain MRI results; however, this patient did not undergo a lumbar puncture. One child with PTC demonstrated improvement in visual acuity and optic nerve appearance after acetazolamide and weight loss therapy. The 2 additional patients with PTC were treated with either low-dose acetazolamide or weight loss therapy and experienced optic atrophy. The final patient, who did not undergo lumbar puncture, experienced spontaneous resolution of optic nerve elevation. Mean follow-up duration was 49 months. Conclusions Only 3.4% (4/117) of Down syndrome children were found to have optic nerve elevation in a single institution. Pseudotumor cerebri should be considered in asymptomatic Down syndrome patients with elevated optic nerves. Medical therapy in PTC with acetazolamide can lead to improvement in visual acuity and optic nerve appearance, although optic atrophy also was seen. To report 4 pediatric Down syndrome patients with optic nerve elevation and pseudotumor cerebri. Retrospective observational case series. Four pediatric Down syndrome patients found to have optic nerve elevation on ophthalmologic examination at a single institution. Medical record review of 117 pediatric Down syndrome patients aged 0 to 18 years was performed. All patients were seen at the University of Wisconsin pediatric ophthalmology clinic between 1995 and 2005. Visual acuity, optic nerve appearance, and neurologic work-up. Four (3.4%) of 117 Down syndrome patients seen at the university’s pediatric ophthalmology clinic were found to have optic nerve elevation. This included 2 boys and 2 girls, aged 2 to 10 years. None of the patients had a history of headache or transient visual obscuration. One of the patients had high hyperopia at the time of presentation, and all were referred for neurologic evaluation of suspected increased intracranial pressure. Three patients were diagnosed with pseudotumor cerebri (PTC) based on a normal brain magnetic resonance imaging (MRI) scan, an elevated opening cerebrospinal fluid (CSF) pressure on lumbar puncture, and normal CSF analysis results. The fourth patient’s elevated optic nerve appearance was likely secondary to PTC after obtaining normal brain MRI results; however, this patient did not undergo a lumbar puncture. One child with PTC demonstrated improvement in visual acuity and optic nerve appearance after acetazolamide and weight loss therapy. The 2 additional patients with PTC were treated with either low-dose acetazolamide or weight loss therapy and experienced optic atrophy. The final patient, who did not undergo lumbar puncture, experienced spontaneous resolution of optic nerve elevation. Mean follow-up duration was 49 months. Only 3.4% (4/117) of Down syndrome children were found to have optic nerve elevation in a single institution. Pseudotumor cerebri should be considered in asymptomatic Down syndrome patients with elevated optic nerves. Medical therapy in PTC with acetazolamide can lead to improvement in visual acuity and optic nerve appearance, although optic atrophy also was seen." @default.
• W2015683003 created "2016-06-24" @default.
• W2015683003 creator A5006621405 @default.
• W2015683003 creator A5041574690 @default.
• W2015683003 date "2007-09-01" @default.
• W2015683003 modified "2023-09-24" @default.
• W2015683003 title "Pseudotumor Cerebri in Children with Down Syndrome" @default.
• W2015683003 cites W1971977811 @default.
• W2015683003 cites W1981632323 @default.
• W2015683003 cites W1992758972 @default.
• W2015683003 cites W2002261691 @default.
• W2015683003 cites W2014779600 @default.
• W2015683003 cites W2083237162 @default.
• W2015683003 cites W2092203161 @default.
• W2015683003 cites W2093647361 @default.
• W2015683003 cites W2115767391 @default.
• W2015683003 cites W2128272694 @default.
• W2015683003 cites W2146516513 @default.
• W2015683003 cites W2169396023 @default.
• W2015683003 cites W2169783815 @default.
• W2015683003 cites W4212878078 @default.
• W2015683003 cites W4235085679 @default.
• W2015683003 doi "https://doi.org/10.1016/j.ophtha.2006.12.015" @default.
• W2015683003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17368546" @default.
• W2015683003 hasPublicationYear "2007" @default.
• W2015683003 type Work @default.
• W2015683003 sameAs 2015683003 @default.
• W2015683003 citedByCount "20" @default.
• W2015683003 countsByYear W20156830032013 @default.
• W2015683003 countsByYear W20156830032014 @default.
• W2015683003 countsByYear W20156830032015 @default.
• W2015683003 countsByYear W20156830032016 @default.
• W2015683003 countsByYear W20156830032019 @default.
• W2015683003 countsByYear W20156830032020 @default.
• W2015683003 countsByYear W20156830032021 @default.
• W2015683003 countsByYear W20156830032022 @default.
• W2015683003 countsByYear W20156830032023 @default.
• W2015683003 crossrefType "journal-article" @default.
• W2015683003 hasAuthorship W2015683003A5006621405 @default.
• W2015683003 hasAuthorship W2015683003A5041574690 @default.
• W2015683003 hasConcept C118487528 @default.
• W2015683003 hasConcept C126322002 @default.
• W2015683003 hasConcept C126838900 @default.
• W2015683003 hasConcept C141071460 @default.
• W2015683003 hasConcept C143409427 @default.
• W2015683003 hasConcept C187212893 @default.
• W2015683003 hasConcept C2776367607 @default.
• W2015683003 hasConcept C2777405951 @default.
• W2015683003 hasConcept C2778107024 @default.
• W2015683003 hasConcept C2778257484 @default.
• W2015683003 hasConcept C2779651940 @default.
• W2015683003 hasConcept C2780066322 @default.
• W2015683003 hasConcept C2780837183 @default.
• W2015683003 hasConcept C2780954326 @default.
• W2015683003 hasConcept C2994005214 @default.
• W2015683003 hasConcept C42219234 @default.
• W2015683003 hasConcept C71924100 @default.
• W2015683003 hasConceptScore W2015683003C118487528 @default.
• W2015683003 hasConceptScore W2015683003C126322002 @default.
• W2015683003 hasConceptScore W2015683003C126838900 @default.
• W2015683003 hasConceptScore W2015683003C141071460 @default.
• W2015683003 hasConceptScore W2015683003C143409427 @default.
• W2015683003 hasConceptScore W2015683003C187212893 @default.
• W2015683003 hasConceptScore W2015683003C2776367607 @default.
• W2015683003 hasConceptScore W2015683003C2777405951 @default.
• W2015683003 hasConceptScore W2015683003C2778107024 @default.
• W2015683003 hasConceptScore W2015683003C2778257484 @default.
• W2015683003 hasConceptScore W2015683003C2779651940 @default.
• W2015683003 hasConceptScore W2015683003C2780066322 @default.
• W2015683003 hasConceptScore W2015683003C2780837183 @default.
• W2015683003 hasConceptScore W2015683003C2780954326 @default.
• W2015683003 hasConceptScore W2015683003C2994005214 @default.
• W2015683003 hasConceptScore W2015683003C42219234 @default.
• W2015683003 hasConceptScore W2015683003C71924100 @default.
• W2015683003 hasIssue "9" @default.
• W2015683003 hasLocation W20156830031 @default.
• W2015683003 hasLocation W20156830032 @default.
• W2015683003 hasOpenAccess W2015683003 @default.
• W2015683003 hasPrimaryLocation W20156830031 @default.
• W2015683003 hasRelatedWork W1969215649 @default.
• W2015683003 hasRelatedWork W1981632323 @default.
• W2015683003 hasRelatedWork W2015683003 @default.
• W2015683003 hasRelatedWork W2022803144 @default.
• W2015683003 hasRelatedWork W2419174278 @default.
• W2015683003 hasRelatedWork W2424096674 @default.
• W2015683003 hasRelatedWork W2957768544 @default.
• W2015683003 hasRelatedWork W3156344347 @default.
• W2015683003 hasRelatedWork W4210832519 @default.
• W2015683003 hasRelatedWork W4303983073 @default.
• W2015683003 hasVolume "114" @default.
• W2015683003 isParatext "false" @default.
• W2015683003 isRetracted "false" @default.
• W2015683003 magId "2015683003" @default.
• W2015683003 workType "article" @default.